Also, the PS19 tauopathy model, which expresses FTD-associated P301S mutant tau, shows abnormal levels of glutamate and glutamine in the parahippocampal and hippocampal regions of the brain, respectively, in an age-dependent manner (Vemula et al., 2019). The gene discussed is MAPT; the disease is tauopathy.